Table of Contents Author Guidelines Submit a Manuscript
Genetics Research International
Volume 2011, Article ID 483851, 9 pages
http://dx.doi.org/10.4061/2011/483851
Research Article

Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population

1Genetic Department, Faculty of Veterinary Medicine, Yüzünci Yil University, Zeve Campus, 65080 Van, Turkey
2Department of Medical Biology and Genetics, Faculty of Medicine, Firat University, 23119 Elazig, Turkey
3Psychiatry Hospital, 23200 Elazig, Turkey

Received 30 September 2010; Revised 22 December 2010; Accepted 31 December 2010

Academic Editor: Haim Werner

Copyright © 2011 Ulku Özbey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jablensky, “Schizophrenia and Cancer: is there a need to invoke a protective gene?” Archives of General Psychiatry, vol. 58, no. 6, pp. 579–580, 2001. View at Google Scholar · View at Scopus
  2. W. Gulbinat, A. Dupont, A. Jablensky et al., “Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries,” The British Journal of Psychiatry, no. 18, pp. 75–83, 1992. View at Google Scholar · View at Scopus
  3. P. B. Mortensen, “The occurrence of cancer in first admitted schizophrenic patients,” Schizophrenia Research, vol. 12, no. 3, pp. 185–194, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. V. S. Catts and S. V. Catts, “Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?” Schizophrenia Research, vol. 41, no. 3, pp. 405–415, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Sidransky and M. Hollstein, “Clinical implications of the p53 gene,” Annual Review of Medicine, vol. 47, pp. 285–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Biroš, I. Kalina, A. Kohút, J. Štubňa, and J. Šalagovič, “Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer,” Lung Cancer, vol. 31, no. 2-3, pp. 157–162, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kawajiri, K. Nakachi, K. Imai, J. Watanabe, and S. I. Hayashi, “Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer,” Carcinogenesis, vol. 14, no. 6, pp. 1085–1089, 1993. View at Google Scholar · View at Scopus
  8. S. Wang-Gohrke, T. R. Rebbeck, W. Besenfelder, R. Kreienberg, and I. B. Runnebaum, “P53 germline polymorphisms are associated with an increased risk for breast cancer in German women,” Anticancer Research, vol. 18, no. 3 B, pp. 2095–2099, 1998. View at Google Scholar · View at Scopus
  9. A. Sjalander, R. Birgander, A. Kivela, and G. Beckman, “p53 polymorphisms and haplotypes in different ethnic groups,” Human Heredity, vol. 45, no. 3, pp. 144–149, 1995. View at Google Scholar · View at Scopus
  10. X. Xie, J. Ott, and B. Gerdes, “Testing linkage disequilibrium between a disease gene and marker loci,” American Journal of Human Genetics, vol. 53, no. 1, pp. 1107–597, 1993. View at Google Scholar
  11. A. F. Gazdar and M. J. Thun, “Lung cancer, smoke exposure, and sex,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 469–471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Skuladottir, J. H. Olsen, and F. R. Hirsch, “Incidence of lung cancer in Denmark: historical and actual status,” Lung Cancer, vol. 27, no. 2, pp. 107–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. I. Henschke, D. P. Naidich, D. F. Yankelevitz et al., “Early lung cancer action project: initial results of annual repeat screening,” Cancer, vol. 92, pp. 153–159, 2001. View at Google Scholar
  14. C. Fidaner, S. Y. Eser, and D. M. Parkin, “Incidence in Izmir in 1993–1994: first results from Izmir Cancer Registry,” European Journal of Cancer, vol. 37, no. 1, pp. 83–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Gürsel, E. Levent, C. Öztürk, and A. Karalezli, “Hospital based survey of lung cancer in Turkey, a developing country, where smoking is highly prevalent,” Lung Cancer, vol. 21, no. 2, pp. 127–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. C. T. Lee, K. H. Kang, Y. Koh et al., “Characteristics of lung cancer in Korea, 1997,” Lung Cancer, vol. 30, no. 1, pp. 15–22, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Peng, Y. Shen, and Z. Wang, “Analysis on the surveillance materials of primary lung cancer from 1989 to 1994 in Shanghai,” Respirology, vol. 3s, p. A38, 1998. View at Google Scholar
  18. W. D. Travis, J. Lubin, L. Ries, and S. Devesa, “United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females,” Cancer, vol. 77, no. 12, pp. 2464–2470, 1996. View at Google Scholar · View at Scopus
  19. I. Tanaka, O. Matsubara, T. Kasuga, T. Takemura, and M. Inoue, “Increasing incidence and changing histopathology of primary lung cancer in Japan: a review of 282 autopsied cases,” Cancer, vol. 62, no. 5, pp. 1035–1039, 1988. View at Google Scholar · View at Scopus
  20. A. Charloux, M. Rossignol, A. Purohit et al., “International differences in epidemiology of lung adenocarcinoma,” Lung Cancer, vol. 16, no. 2-3, pp. 133–143, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. E. L. Wynder and D. Hoffmann, “Smoking and lung cancer: scientific challenges and opportunities,” Cancer Research, vol. 54, no. 20, pp. 5284–5295, 1994. View at Google Scholar · View at Scopus
  22. P. C. Hoffman, A. M. Mauer, and E. E. Vokes, “Lung cancer,” Lancet, vol. 355, no. 9202, pp. 479–485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Landis, T. Murray, S. Bolden, and P. A. Wingo, “Cancer statistics, 1998,” Cancer Journal for Clinicians, vol. 48, no. 1, pp. 6–29, 1998. View at Google Scholar · View at Scopus
  24. Y. J. Lim, J. W. Kim, JI. Y. Song et al., “Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population,” Neuroscience Letters, vol. 374, no. 3, pp. 157–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Själander, R. Birgander, G. Hallmans et al., “p53 polymorphisms and haplotypes in breast cancer,” Carcinogenesis, vol. 17, no. 6, pp. 1313–1316, 1996. View at Google Scholar · View at Scopus
  26. H. J. Chiu, Y. C. Wang, J. Y. Chen, C. J. Hong, and S. J. Tsai, “Association study of the p53-gene Pro72Arg polymorphism in schizophrenia,” Psychiatry Research, vol. 105, no. 3, pp. 279–283, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. E. A. Komarova, M. V. Chernov, R. Franks et al., “Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo,” EMBO Journal, vol. 16, no. 6, pp. 1391–1400, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Biroš, I. Kalina, A. Kohút, E. Bogyiová, J. Šalagovič, and I. Šulla, “Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients,” Physiological Research, vol. 51, no. 1, pp. 59–64, 2002. View at Google Scholar · View at Scopus
  29. YI. C. Wang, C. Y. Chen, S. K. Chen, Y. Y. Chang, and P. Lin, “p53 Codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis,” Clinical Cancer Research, vol. 5, no. 1, pp. 129–134, 1999. View at Google Scholar · View at Scopus
  30. M. Murata, M. Tagawa, H. Kimura, K. Kakisawa, H. Shirasawa, and T. Fujisawa, “Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients,” International Journal of Oncology, vol. 12, no. 3, pp. 577–581, 1998. View at Google Scholar · View at Scopus
  31. R. Fan, M. T. Wu, D. Miller et al., “The p53 codon 72 polymorphism and lung cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 9, no. 10, pp. 1037–1042, 2000. View at Google Scholar · View at Scopus
  32. A. Weston, L. S. Perrin, K. Forrester et al., “Allelic frequency of a p53 polymorphism in human lung cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 1, no. 6, pp. 481–483, 1992. View at Google Scholar · View at Scopus
  33. X. Jin, X. Wu, J. A. Roth et al., “Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype,” Carcinogenesis, vol. 16, no. 9, pp. 2205–2208, 1995. View at Google Scholar · View at Scopus
  34. B. G. Campling and W. S. el-Deiry, “Clinical implications of p53 mutations in lung cancer,” Methods in Molecular Medicine, vol. 75, pp. 53–77, 2003. View at Google Scholar · View at Scopus
  35. Y. C. Wang, H. S. Lee, S. K. Chen, and Y. Y. Chang, “Prognostic significance of p53 codon 72 polymorphism in lung carcinomas,” European Journal of Cancer, vol. 35, no. 2, pp. 226–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Birgander, A. Sjalander, A. Rannug et al., “P53 polymorphisms and haplotypes in lung cancer,” Carcinogenesis, vol. 16, no. 9, pp. 2233–2236, 1995. View at Google Scholar · View at Scopus